The Mortgage Bankers Association (MBA) released its weekly report on mortgage applications Wednesday morning, noting a decrease of 0.5% in the group’s seasonally adjusted composite index for the week ending June 29. Mortgage loan rate movements were mixed last week.
(1) Tesla (TSLA) will reportedly start producing its Model Y sport utility vehicle in November 2019. Can we just say what sane people (not the Tesla fanatics who continue to shred me on Twitter each day) are probably thinking: How in the world is Tesla going to successfully produce another vehicle, a more complex....More>>>
Denali Therapeutics Inc. (NASDAQ: DNLI) entered the markets with a bang on Friday. In its initial public offering (IPO), the company priced its 13.89 million shares at $18 apiece, within the expected range of $17 to $19 per share. There is an overallotment option for an additional 2.08 million shares. At this price, the entire offering is valued up to $287.5 million.
General Electric (NYSE:GE) is one of the most outstanding dividend plays out there. Not only has the company paid out a dividend for more than 100 uninterrupted years, it has also grown that dividend in most years. GE’s current yield of 3% is considerably higher than the Dow Jones Industrial Average (INDX:INDU) average yield of 2.76%.
Anything that would threaten that dividend is, therefore,....More>>>
The mainstream media is comparing Bitcoin to the “Tulip Mania” of the 17th century, a famous speculative bubble of tulip prices. But Bitcoin is not in a price bubble…
During Tulip Mania, tulips would soar to such astronomical value that 10 tulip bulbs could buy a mansion. Prices eventually collapsed in 1637, making the flower worthless and creating a lesson for all....More>>>
Employing contrarian investing tactics is exceptionally difficult. Evolutionarily speaking, we are inclined to follow the majority and not stray from the pack. However, in investing, it can be extraordinarily lucrative to deviate from the consensus. The consensus view of Bed Bath & Beyond (NASDAQ:BBBY) is that the company faces several headwinds that will stagnate growth and cause the stock....More>>>
Consolidation in the refining sector is a clear signal towards the expected fall in crack spreads. Although crack spreads were already falling, M&A activity in the sector cements this belief that the time of low oil prices might be coming to an end. Tesoro’s (NYSE:TSO) acquisition of Western Refining (NYSE:WNR) serves a number of purposes for the company. The issue of weakening crack spreads....More>>>
A growing number of parents of children ages 17 and older say they’re repaying their children’s college debt, according to a new analysis by USC researchers. About 13% of parents around age 50 reported paying off their children’s student loans.
They’re also borrowing more. From the 1995-96 academic year to the 2015-16 academic year, borrowers for Parent Loans for Undergraduate....More>>>
SOFIA, Bulgaria The European Union has called on U.S. President Donald Trump's administration to stop threating it with tariffs on steel and aluminum, saying Thursday it is prepared to discuss trade but not at gun-point.
In March, Trump slapped tariffs of 25% on steel imports and 10% on impo
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one high-profile Wall Street pick and putting it under the microscope...
Editor's note: Seeking Alpha is proud to welcome Michael McGrath as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more 禄
If you're not familiar with how Social Security works, you might assume that there's a single age at which eligible recipients have to file for benefits. Not so. You actually get an eight-year window to claim benefits that begins at age 62 and carries through until age 70. (Technically, you're no
The biopharma and drug supply chain sectors outperformed the market last week, even as Trump administration officials pressed the president's blueprint to lower drug prices, with tough rhetoric for drugmakers and public shaming of pharmaceutical firms for supposedly blocking competition.